July 2014
By Raveena Bhambra
Q2 was full of deals, coupled with the talk of potential deals, and overall it finished on a high with a large volume of agreements coming together in June.
Key findings
- Over 500 partnership deals announced during Q2
- Four deals valued at over $1billion
- The leading therapy deal of the quarter was a partnership focused on Crohn’s disease
- Pfizer was the most active big pharma dealmaker
The following article is a summary of the key partnership deal pharma trends of Q2 covering highest value deals, top industry and therapy deals. We also look at the top five deals by headline value during the period and display their details, plus links to each full deal record are supplied by our proprietary deals and alliances database Current Agreements.
Premium content
The remaining part of this article is Premium content – see below for access options.
Purchase this article
$35.00 BUY NOW
For $35.00, purchase this 3,095-word article and receive immediate online access.
100% Satisfaction Guarantee.
Already a subscriber?
Access to this area requires a CP Insight subscription.Subscription options
View for more information on pricing
Have a question?
Related
Report: Bigpharma Deals and Alliances of 2013
Report: Merger and Acquisition Deals and Alliances of 2013
Browse: Complete Current Partnering report catalog
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter
Current Partnering
Current Partnering provides industry executives with partnering best practice and essential business intelligence. Further details about the range of reports and subscription services offered can be found at our website:
This article was published July 2014.
For inquiries about the content of this article, please contact:
Email: enquiry@currentpartnering.com
Mail: Current Partnering
Wildwood Ventures Ltd
Allanmere House
6 Hobgate
York
YO24 4HF
United Kingdom
All rights reserved.
